Melinta Therapeutics Acquires US Rights to TOPROL-XL
By, Admin1 min read
Share
Melinta Therapeutics, LLC, a commercial-stage company providing innovative therapies for acute and life-threatening illnesses, announced today that it has acquired the U.S. rights to TOPROL-XL
Found this useful? Share it with your team.
Newsletter
Stay ahead with Clival insights
Subscribe to get the latest updates, data releases and industry information — straight to your inbox.
